Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635100 · ClinicalTrials.gov registry record · NA
Multinight CPAP for Sleep Apnea Patients
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02635100 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 1 participants.
The verdict
NCT02635100, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) is a prevalent disorders characterized by intermittent obstructions of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) has been shown to be the most efficacious treatment for OSA. It consists of a small device that provides positive airway pressure delivered by a mask attached to the patients nose/mouth.
Interventions
- OTHER CPAP machine with MNT algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02635100
The ClinicalTrials.gov registry entry for NCT02635100 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CPAP machine with MNT algorithm is the first listed.
NCT02635100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02635100 about?
NCT02635100 is a clinical study titled "Multinight CPAP for Sleep Apnea Patients". Obstructive sleep apnea (OSA) is a prevalent disorders characterized by intermittent obstructions of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) has been shown to be the most efficacious treatment for OSA. It consists of a small device that provides positive airway pres...
What is the current status of trial NCT02635100?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2015-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02635100?
The interventions under investigation include: CPAP machine with MNT algorithm (OTHER).
Who is sponsoring clinical trial NCT02635100?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.